Top 10 European VCs investing in the AI Drug Discovery sector

Portugal Business News - Valerie Charoux
Dec 9, 2025
3 min read

Biotech News Europe – Here is the ranking of the Top 10 European VCs investing in the Biotech and AI Drug Discovery sector, according to a Dealroom report dated December 2025:

Top 10 European VCs investing in the Biotech and AI Drug Discovery sector in 2025:

1 – Nina Capital – Barcelona, Spain

Nina Capital ranks No. 1 VC in Europe investing in the Biotech and AI Drug Discovery sector with 6 investment rounds representing 8.22% of total rounds.

Nina Capital usually invests in Seed funding rounds, and its biotech drug discovery portfolio startups include Cryocloud and Zetta Genomics.

2 – Speedinvest – Vienna, Austria

Speedinvest ranks 2^nd VC in Europe investing in the Biotech and AI Drug Discovery sector with 5 investment rounds representing 0.9% of total rounds.

Speedinvest usually invests in Seed funding rounds, and its biotech drug discovery portfolio startups include Rivia and Aerska.

3 – High-Tech Gründerfonds – Bonn, Germany

High-Tech Gründerfonds ranks 3^rd VC in Europe investing in the Biotech and AI Drug Discovery sector with 4 investment rounds representing 0.48% of total rounds.

High-Tech Gründerfonds usually invests in Seed funding rounds, and its biotech drug discovery portfolio startups include AI gnostics and Certivity.

4 – Verve Ventures – Zürich, Switzerland

Verve Ventures ranks 4^th VC in Europe investing in the Biotech and AI Drug Discovery sector with 4 investment rounds representing 1.46% of total rounds.

Verve Ventures usually invests in Series A funding rounds, and its biotech drug discovery portfolio startups include Nuclera and CellVoyant.

5 – BlueYard Capital – Berlin, Germany

BlueYard Capital ranks 5^th VC in Europe investing in the Biotech and AI Drug Discovery sector with 4 investment rounds representing 4.44% of total rounds.

BlueYard Capital usually invests in Seed funding rounds, and its biotech drug discovery portfolio startups include bit.bio and Biofidelity.

6 – APEX Ventures – Vienna, Austria

APEX Ventures ranks 6^th VC in Europe investing in the Biotech and AI Drug Discovery sector with 4 investment rounds representing 6.45% of total rounds.

APEX Ventures usually invests in Seed funding rounds, and its biotech drug discovery portfolio startups include Quibim and CardiaTec.

7 – b2venture – St Gallen, Switzerland

B2venture ranks 7^th VC in Europe investing in the Biotech and AI Drug Discovery sector with 4 investment rounds representing 1.44% of total rounds.

B2venture usually invests in Seed funding rounds, and its biotech drug discovery portfolio startups include Healx and Kiin Bio.

8 – Atomico – London, UK

Atomico ranks 8^th VC in Europe investing in the Biotech and AI Drug Discovery sector with 3 investment rounds representing 1.14% of total rounds.

Atomico usually invests in Series A funding rounds, and its biotech drug discovery portfolio startups include LabGenius and R.grid.

9 – Sofinnova – Paris, France

Sofinnova ranks 9^th VC in Europe investing in the Biotech and AI Drug Discovery sector with 3 investment rounds representing 0.84% of total rounds.

Sofinnova usually invests in Series A funding rounds, and its biotech drug discovery portfolio startups include Bioptimus and Latent Labs.

10 – Redalpine – Zürich, Switzerland

Redalpine ranks 10^th VC in Europe investing in the Biotech and AI Drug Discovery sector with 3 investment rounds representing 1.78% of total rounds.

Redalpine usually invests in Seed funding rounds, and its biotech drug discovery portfolio startups include ExpressionEdits and Valink Therapeutics.